| Application no. and date | 17790643.5 (espacenet) (Federated) (European Patent Register), 20170501 | | Patent/reg. no. and date | DK/EP 3448378, 20240417 | | Publication date | 20190306 | | Priority no. and date | US 201662329611 P, 20160429, US 201662340075 P, 20160523, US 201662423693 P, 20161117 | | EP pub. no. and date |
EP 3448378 20190306 | | Effective date | | | Applicant/owner | Ophirex, Inc., 5643 Paradise Drive No. 2
Corte Madera, CA 94925, US | | Applicant ref. no. | | | Inventor | LEWIN, Matthew R., c/o Ophirex Inc.
5643 Paradise Drive 2
Corte Madera
California 94925, US | | Representative | | | Opponent | | | IPC Class | A61K 31/16 (2006.01) , A61K 31/19 (2006.01) , A61K 31/192 (2006.01) , A61K 31/22 (2006.01) , A61K 31/366 (2006.01) , A61K 31/40 (2006.01) , A61K 31/404 (2006.01) , A61K 31/437 (2006.01) , A61K 45/06 (2006.01) , A61P 39/02 (2006.01) | | Title | PLA2 AND HMG-COA INHIBITORS FOR TREATMENT OF PATHOLOGICAL CONDITIONS CAUSING HEMOLYSIS, CEREBRAL EDEMA, AND ACUTE KIDNEY INJURY | | Int. application no. | US2017030436 | | Int. publication no. | WO2017190141 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
